Systematic analysis of English requirements in US-based clinical trials for diseases disproportionately distributed among ethnicities
Authors: Pranic, Shelly Melissa; Bazdaric, Ksenija; Estevao, Maria Dulce; Perez-Neri, Ivan; Mishra, Vinayak; McGriff, Joanne A; Pulumati, Anika
Source journal: Communications medicine (2026-07-24)
DOI: 10.1038/s43856-026-01810-4
Abstract
BACKGROUND: Language requirements for enrollment in randomized controlled trials (RCTs) are rarely stated; however, due to intersectionality of language, race, and ethnicity, assessing language stipulations in trials on diseases disproportionally affect racially and ethnically diverse individuals is needed. We investigated language requirement frequency, eligibility criteria readability, and race and ethnicity reporting from RCTs in high-impact publications and public database ClinicalTrials.gov. METHODS: This cohort study included 35 RCTs and 42723 participants from systematic searches in MEDLINE, Scopus, EBSCO, Web of Science Core Collection, World Health Organization COVID-19 database April 2017-December 2025. We included drug RCTs on heart disease, stroke, cancer, respiratory disease, diabetes, and COVID-19, on ClinicalTrials.gov and published with >/=75% US participants. We assessed language requirements frequency in eligibility criteria in publications, protocols, informed consent forms, and ClinicalTrials.gov, and readability of consent forms and eligibility criteria in protocols and ClinicalTrials.gov according to funder and disease. RESULTS: We report 58% of industry-funded RCTs lack mention of languages in eligibility criteria or trial documentation. The median (IQR) readability of eligibility criteria assessed with Flesch-Kincaid Grade (FKG), Gunning Fog (GF), and Simplified Measure of Gobbledygook (SMOG) is higher than the recommended eighth-grade level in protocols with FKG = 12.7 (11.0-13.9), GF = 14.5 (12.4-15.4), and SMOG = 13.7 (12.1-14.4) and ClinicalTrials.gov with FKG = 12.9 (10.8-13.9), GF = 14.0 (12.2-15.3), and SMOG = 13.9 (12.2-15.6). Informed consent forms also have reading grade levels higher than recommended for the general public, with FKG = 8.2 (7.3-9.3), GF = 9.3 (8.8-10.8), and SMOG = 10.8 (10.2-11.8). CONCLUSIONS: Involving stakeholders during RCT design is needed to encourage explicit language reporting and high readability, which could be instrumental in RCT accessibility and equity.
Related topics
Related open access articles
- CHALLENGES IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH COLORECTAL CANCER AND COVID-19 COINFECTION - CASE REPORT
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- The use of non-invasive ventilation (NIV) in the treatment of patients with COVID-19
- Application of Nanotechnology in Treatment of COVID-19
- Nano Platforms in Combatting COVID-19: Unveiling Antiviral Strategies and Challenges
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.